Imperial College London

ProfessorMichaelSeckl

Faculty of MedicineDepartment of Surgery & Cancer

Professor of Molecular Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 3311 1421m.seckl

 
 
//

Location

 

08Cyclotron buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Bergamini:2021:10.1016/j.ejca.2021.05.002,
author = {Bergamini, A and Sarwar, N and Ferrandina, G and Scarfone, G and Short, D and Aguiar, X and Camnasio, C and Kaur, B and Savage, PM and Cormio, G and Lim, A and Pignata, S and Mangili, G and Seckl, MJ},
doi = {10.1016/j.ejca.2021.05.002},
journal = {EUROPEAN JOURNAL OF CANCER},
pages = {257--258},
title = {Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis},
url = {http://dx.doi.org/10.1016/j.ejca.2021.05.002},
volume = {152},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Bergamini,A
AU - Sarwar,N
AU - Ferrandina,G
AU - Scarfone,G
AU - Short,D
AU - Aguiar,X
AU - Camnasio,C
AU - Kaur,B
AU - Savage,PM
AU - Cormio,G
AU - Lim,A
AU - Pignata,S
AU - Mangili,G
AU - Seckl,MJ
DO - 10.1016/j.ejca.2021.05.002
EP - 258
PY - 2021///
SN - 0959-8049
SP - 257
TI - Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis
T2 - EUROPEAN JOURNAL OF CANCER
UR - http://dx.doi.org/10.1016/j.ejca.2021.05.002
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000678059500029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 152
ER -